Shopping Cart 0
Cart Subtotal
USD 0

GeoVax Labs Inc (GOVX)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

GeoVax Labs Inc (GOVX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company's vaccine development programs focus on human immunodeficiency virus (HIV), Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B subtype of the HIV virus and clade C subtype. The company developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

May 08,2017: GeoVax Reports 2017 First Quarter Financial Results and Development Program Updates

Mar 27,2017: GeoVax Reports on Vaccine Development Progress

Mar 24,2017: GeoVax Reports 2016 Year-End Financial Results

Jan 03,2017: GeoVax Announces Formation of Scientific Advisory Board

Dec 14,2016: GeoVax Announces Appointment of Farshad Guirakhoo, PhD as Chief Scientific Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

GeoVax Labs Inc-Key Facts 6

GeoVax Labs Inc-Key Employees 7

GeoVax Labs Inc-Key Employee Biographies 8

GeoVax Labs Inc-Major Products and Services 9

GeoVax Labs Inc-Pharmaceutical Pipeline Products Data 10

GeoVax Labs Inc, Pipeline Products by Therapy Area 10

GeoVax Labs Inc, Pipeline Products by Development Phase 11

GeoVax Labs Inc-History 12

GeoVax Labs Inc-Company Statement 14

GeoVax Labs Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

GeoVax Labs Inc-Business Description 17

GeoVax Labs Inc-Corporate Strategy 18

GeoVax Labs Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

GeoVax Labs Inc-Strengths 19

GeoVax Labs Inc-Weaknesses 20

GeoVax Labs Inc-Opportunities 21

GeoVax Labs Inc-Threats 22

GeoVax Labs Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31

GeoVax Labs Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

May 08, 2017: GeoVax Reports 2017 First Quarter Financial Results and Development Program Updates 33

Mar 27, 2017: GeoVax Reports on Vaccine Development Progress 34

Mar 24, 2017: GeoVax Reports 2016 Year-End Financial Results 36

Jan 03, 2017: GeoVax Announces Formation of Scientific Advisory Board 37

Dec 14, 2016: GeoVax Announces Appointment of Farshad Guirakhoo, PhD as Chief Scientific Officer 39

Nov 11, 2016: GeoVax Reports 2016 Third Quarter Financial Results and Provides Corporate Update 40

Oct 03, 2016: GeoVax to Present at Upcoming Scientific Conferences on its Hemorrhagic Fever and Zika Vaccine Programs 42

Aug 05, 2016: GeoVax Reports 2016 Second Quarter Financial Results and Provides Corporate Update 43

May 04, 2016: GeoVax Reports 2016 First Quarter Financial Results 44

Mar 16, 2016: GeoVax Reports 2015 Year-End Financial Results And Provides Corporate Update 45

Section 6-Appendix 46

Methodology 46

Ratio Definitions 46

About GlobalData 50

Contact Us 50

Disclaimer 50


List Of Figure

List of Figures

GeoVax Labs Inc, Pipeline Products by Therapy Area 10

GeoVax Labs Inc, Pipeline Products by Development Phase 11

GeoVax Labs Inc, Performance Chart (2012-2016) 27

GeoVax Labs Inc, Ratio Charts 29

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31


List Of Table

List of Tables

GeoVax Labs Inc, Key Facts 6

GeoVax Labs Inc, Key Employees 7

GeoVax Labs Inc, Key Employee Biographies 8

GeoVax Labs Inc, Major Products and Services 9

GeoVax Labs Inc, Number of Pipeline Products by Therapy Area 10

GeoVax Labs Inc, Number of Pipeline Products by Development Stage 11

GeoVax Labs Inc, History 12

GeoVax Labs Inc, Subsidiaries 16

GeoVax Labs Inc, Key Competitors 23

GeoVax Labs Inc, Ratios based on current share price 24

GeoVax Labs Inc, Annual Ratios 25

GeoVax Labs Inc, Annual Ratios (Cont...1) 26

GeoVax Labs Inc, Interim Ratios 28

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31

GeoVax Labs Inc, Recent Deals Summary 32

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com